Reports for SANDOZ CANADA INCORPORATED
Company Name
SANDOZ CANADA INCORPORATED
Totals |
||
Shortage reports |
2266 |
|
| Actual shortage: | 50 (2%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 19 (1%) | |
| Resolved: | 2197 (97%) | |
Discontinuation Reports |
124 |
|
| To be discontinued: | 4 (3%) | |
| Discontinued: | 118 (95%) | |
| Reversed: | 2 (2%) | |
Late reports |
451 (19%) |
|
Overdue reports |
13 (24%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| PANTOPRAZOLE SODIUM FOR INJECTION | 40MG | POWDER FOR SOLUTION | Resolved | 2021-09-20 | 2021-09-28 | 145907 |
| PANTOPRAZOLE SODIUM FOR INJECTION | 40MG | POWDER FOR SOLUTION | Resolved | 2021-10-19 | 2021-11-16 | 147573 |
| PANTOPRAZOLE SODIUM FOR INJECTION | 40MG | POWDER FOR SOLUTION | Resolved | 2022-10-19 | 2022-12-28 | 172178 |
| PANTOPRAZOLE SODIUM FOR INJECTION | 40MG | POWDER FOR SOLUTION | Resolved | 2023-08-07 | 2023-10-03 | 201273 |
| PANTOPRAZOLE SODIUM FOR INJECTION | 40MG | POWDER FOR SOLUTION | Resolved | 2023-10-30 | 2023-11-15 | 208546 |
| PANTOPRAZOLE SODIUM FOR INJECTION | 40MG | POWDER FOR SOLUTION | Resolved | 2023-12-19 | 2024-02-20 | 213817 |
| PANTOPRAZOLE SODIUM FOR INJECTION | 40MG | POWDER FOR SOLUTION | Resolved | 2024-02-26 | 2025-07-29 | 220548 |
| PAPAVERINE HYDROCHLORIDE INJECTION USP | 65MG | LIQUID | Resolved | 2022-04-06 | 2022-09-27 | 158046 |
| PAPAVERINE HYDROCHLORIDE INJECTION USP | 65MG | LIQUID | Resolved | 2022-12-28 | 2023-03-14 | 179515 |
| PAPAVERINE HYDROCHLORIDE INJECTION USP | 65MG | LIQUID | Resolved | 2023-12-19 | 2024-01-06 | 213882 |
| PAPAVERINE HYDROCHLORIDE INJECTION USP | 65MG | LIQUID | Avoided shortage | 2024-08-08 | 2024-08-15 | 234800 |
| PHENOBARBITAL SODIUM INJECTION, USP | 120MG | SOLUTION | Resolved | 2017-03-14 | 2017-07-05 | 2586 |
| PHENOBARBITAL SODIUM INJECTION, USP | 30MG | SOLUTION | Resolved | 2017-07-11 | 2017-10-27 | 15463 |
| PHENOBARBITAL SODIUM INJECTION, USP | 120MG | SOLUTION | Resolved | 2019-10-15 | 2019-11-01 | 96570 |
| PHENOBARBITAL SODIUM INJECTION, USP | 30MG | SOLUTION | Resolved | 2022-03-25 | 2022-04-20 | 157419 |
| PHENOBARBITAL SODIUM INJECTION, USP | 120MG | SOLUTION | Resolved | 2022-09-01 | 2022-10-05 | 168452 |
| PHENOBARBITAL SODIUM INJECTION, USP | 30MG | SOLUTION | Resolved | 2023-02-09 | 2023-03-04 | 184259 |
| PHENOBARBITAL SODIUM INJECTION, USP | 30MG | SOLUTION | Resolved | 2024-01-08 | 2024-04-04 | 215343 |
| PHENOBARBITAL SODIUM INJECTION, USP | 120MG | SOLUTION | Resolved | 2024-03-11 | 2024-04-24 | 221838 |
| PHENOBARBITAL SODIUM INJECTION, USP | 120MG | SOLUTION | Resolved | 2024-06-03 | 2024-06-13 | 229498 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TOBRAMYCIN INHALATION SOLUTION | 300MG | SOLUTION | Discontinued | 2021-09-02 | 2021-09-02 | 145015 |
| VITAMIN B12 | 100MCG | LIQUID | Discontinued | 2017-06-06 | 2017-07-01 | 12133 |
| ZOFRAN ODT | 8MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2022-12-08 | 2023-03-14 | 177540 |
| ZOFRAN ODT | 4MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2023-03-14 | 2023-03-14 | 187062 |